EBOS (ASX:EBO) share price on watch amid cap raise and $1 billion acquisition

EBOS announced a major acquisition this morning. Here are all the details.

| More on:
A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The EBOS Group Ltd (ASX: EBO) share price is on watch this morning as the company undertakes a capital raise ahead of a $1.1 billion acquisition.

The pharmaceutical wholesaler and distributor is set to purchase the Australian and New Zealand subsidiaries of LifeHealthcare, as well as 51% of the Asian subsidiary, Transmedic.

LifeHealthcare is one of the largest distributors of third party medical devices, consumables, capital equipment, and in-house manufactured allograft material in Australia, New Zealand, and South-East Asia.

The EBOS share price is frozen at $34.70 as it initiates what's expected to be a $742 million capital raise.

Let's take a closer look at what's going on with EBOS on Thursday.

EBOS share price frozen amid acquisition announcement

EBOS believes acquiring LifeHealthcare will diversify and enhance its portfolio. It will also create an entry point for EBOS in the Asia Pacific region.

The remaining portion of Transmedic will be retained by its co-founders. They will continue to manage the business. EBOS states it has entered into arrangements to acquire the remaining 49% of the business "in the medium term".

The purchase will cost the ASX giant $1.167 billion. The company expects the acquisition will bring in between $110 million and $114 million of earnings before interest, tax, depreciation, and amortisation (EBITDA) in 2023.

To fund the acquisition, EBOS is undertaking a non-underwritten retail offer to raise up to $100 million. It is also undertaking a $642 million placement.

The placement will see EBOS shares offered at a price of $32.75 (converted from New Zealand dollars at the current exchange rate). That represents a 5.5% discount on EBOS's previous closing price.

The retail offer will be open to eligible shareholders. It will see the company's stock offered for the placement price or the 5-day volume weighted average price, whichever is lower. The company may accept over-subscriptions.

EBOS will also put $540 million from new term loan debt facilities towards the purchase. EBOS will fund the remaining $23 million by issuing 700,000 new shares to LifeHealthcare management.

The acquisition is subject to several conditions, including regulatory approval. EBOS expects to complete the acquisition by the end of this financial year.

Over FY2021, LifeHealthcare brought in $326 million in pro forma revenue and $92 million in pro forma EBITDA.

EBOS trading update

The EBOS share price is also in focus due to a trading update provided by the company this morning.

Over the first 4 months of FY2022, the company's net profit after tax grew by 14% on that of the prior corresponding period.

EBOS's healthcare segment revenue increased by 10.4%, while its animal care segment revenue rose by 14.3%.

The EBOS group's earnings before interest and tax also increased by 13.1% year-on-year.  

Looking to the future, the company expects that acquiring LifeHealthcare will deliver low double-digit percentage earnings per share (EPS) growth in 2022.

Additionally, EBOS expects its FY2022 dividend to represent between 60% and 80% of its net profit after tax.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Mergers & Acquisitions

Group of people in a gym high five each other surrounded by gym equipment.
Mergers & Acquisitions

This ASX tech stock is hitting a record high on acquisition news

The market is responding positively to this news. Let's dig deeper into it.

Read more »

Two people shaking hands in the boardroom on a merger.
Mergers & Acquisitions

What did Macquarie make of the Brickworks and Soul Patts merger?

Macquarie sees simplification, scale, and upside… but it also has a warning..

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Mergers & Acquisitions

PointsBet share price surges 11% on improved takeover offer

The bidding war for PointsBet shares continues apace today.

Read more »

A couple sit in front of a laptop reading ASX shares news articles and learning about ASX 200 bargain buys
Share Gainers

Why are Soul Patts shares up 9% today?

A marriage proposal has seen investors flock to this company.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Mergers & Acquisitions

Why are Brickworks shares up 18% today?

Let's find out what is getting investors excited this morning.

Read more »

Two hands being shaken symbolising a deal.
Mergers & Acquisitions

Soul Patts to merge with Brickworks shares: What does this mean for investors?

These two blue chips are merging as part of a $14 billion deal.

Read more »

The last piece of the jigsaw being fitted, indicating good news for a share price on merger or acquisition
Mergers & Acquisitions

WiseTech share price storms higher on $3.25b blockbuster acquisition

What is the company spending billions on? Let's find out.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Mergers & Acquisitions

IAG share price lifts off on strategic alliance approval

IAG shares are racing higher in Thursday’s sinking market.

Read more »